Indivior has been granted a patent for a medication component mixing system comprising a female syringe with a unique tapered female coupler that mechanically couples with a male syringe for mixing medication components. The system ensures precise mixing without the male member protruding into the female syringe. GlobalData’s report on Indivior gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Indivior Plc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Indivior, Nanoparticle drug conjugates was a key innovation area identified from patents. Indivior's grant share as of January 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

Medication component mixing system with female and male syringes

Source: United States Patent and Trademark Office (USPTO). Credit: Indivior Plc

The granted patent (Publication Number: US11857498B2) discloses a female syringe system designed with specific structural features to prevent the male syringe from protruding into the internal cavity of the female syringe when coupled together. The system includes a female syringe with a barrel member, a plunger, and a tapered female coupler with a unique lug thread member configuration. This lug thread member prevents the male syringe from extending into the internal cavity of the female syringe, ensuring a secure and safe coupling between the two syringes. The female coupler's cylindrical body has a smooth outer surface, except for the lug thread, and is longer than the male syringe's annular sleeve to accommodate the protrusion length of the male member.

Furthermore, the system includes a male syringe made of cyclic olefin copolymers, while the female syringe is made of polypropylene. The complementary tapers of the male member and the female coupler limit the depth of insertion of the male member into the female syringe, ensuring proper alignment and functionality. The structural design of the female syringe system aims to provide a reliable and efficient mechanism for coupling with a male syringe, enhancing the overall usability and safety of the syringe system for medical or other applications. The patent covers various embodiments of the female syringe system, each emphasizing the unique features and configurations that contribute to the system's effectiveness and performance.

To know more about GlobalData’s detailed insights on Indivior, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies